New-onset refractory status epilepticus (NORSE)--The potential role for immunotherapy. [electronic resource]
Producer: 20160125Description: 17-23 p. digitalISSN:- 1525-5069
- Adult
- Anticonvulsants -- therapeutic use
- Autoantibodies
- Case-Control Studies
- Female
- Glutamate Decarboxylase
- Humans
- Immunoglobulins, Intravenous -- therapeutic use
- Immunotherapy
- Male
- Middle Aged
- Prospective Studies
- Receptors, N-Methyl-D-Aspartate -- immunology
- Seizures -- complications
- Status Epilepticus -- diagnosis
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.